| 1 |
34788765 | Increase in Chondroitin Sulfate and Decline in Arylsulfatase B May Contribute to Pathophysiology of COVID-19 Respiratory Failure. | 2022 |
1 |
| 2 |
34948256 | Mucopolysaccharidosis Type VI, an Updated Overview of the Disease. | 2021 Dec 15 |
1 |
| 3 |
29371215 | Targeting Chondroitin Sulfate Glycosaminoglycans to Treat Cardiac Fibrosis in Pathological Remodeling. | 2018 Jun 5 |
2 |
| 4 |
30335002 | Family study of a novel mutation of mucopolysaccharidosis type VI with a severe phenotype and good response to enzymatic replacement therapy: Case report. | 2018 Oct |
1 |
| 5 |
27926479 | Decline in arylsulfatase B leads to increased invasiveness of melanoma cells. | 2017 Jan 17 |
2 |
| 6 |
29081414 | Arylsulfatase B is reduced in prostate cancer recurrences. | 2017 Dec 12 |
4 |
| 7 |
29245974 | Chondroitin sulfatases differentially regulate Wnt signaling in prostate stem cells through effects on SHP2, phospho-ERK1/2, and Dickkopf Wnt signaling pathway inhibitor (DKK3). | 2017 Nov 21 |
4 |
| 8 |
27078017 | Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF. | 2016 |
4 |
| 9 |
27605497 | Restriction of Aerobic Metabolism by Acquired or Innate Arylsulfatase B Deficiency: A New Approach to the Warburg Effect. | 2016 Sep 8 |
1 |
| 10 |
25511584 | Regulation of chondroitin-4-sulfotransferase (CHST11) expression by opposing effects of arylsulfatase B on BMP4 and Wnt9A. | 2015 Mar |
4 |
| 11 |
24240681 | Arylsulfatase B regulates versican expression by galectin-3 and AP-1 mediated transcriptional effects. | 2014 Nov 20 |
6 |
| 12 |
24778176 | Increased expression of colonic Wnt9A through Sp1-mediated transcriptional effects involving arylsulfatase B, chondroitin 4-sulfate, and galectin-3. | 2014 Jun 20 |
3 |
| 13 |
25190157 | [Analysis of clinical features and arylsulfatase B gene mutation in thirteen Chinese children with mucopolysaccharidosis type VI]. | 2014 Jun |
2 |
| 14 |
22550062 | Reduced Arylsulfatase B activity in leukocytes from cystic fibrosis patients. | 2013 Mar |
3 |
| 15 |
23835622 | Arylsulfatase B (N-acetylgalactosamine-4-sulfatase): potential role as a biomarker in prostate cancer. | 2013 Sep |
7 |
| 16 |
22079206 | Molecular signature of kappa-carrageenan mimics chondroitin-4-sulfate and dermatan sulfate and enables interaction with arylsulfatase B. | 2012 Sep |
2 |
| 17 |
22428001 | Hypoxia reduces arylsulfatase B activity and silencing arylsulfatase B replicates and mediates the effects of hypoxia. | 2012 |
3 |
| 18 |
21378286 | Extra-lysosomal localization of arylsulfatase B in human colonic epithelium. | 2011 Mar |
6 |
| 19 |
19346317 | Cell-bound IL-8 increases in bronchial epithelial cells after arylsulfatase B silencing due to sequestration with chondroitin-4-sulfate. | 2010 Jan |
3 |
| 20 |
20152898 | Arylsulfatase B regulates interaction of chondroitin-4-sulfate and kininogen in renal epithelial cells. | 2010 May |
5 |
| 21 |
20385007 | Mucopolysaccharidosis VI. | 2010 Apr 12 |
1 |
| 22 |
19306108 | Arylsulfatase B regulates colonic epithelial cell migration by effects on MMP9 expression and RhoA activation. | 2009 |
6 |
| 23 |
19682969 | Development of a functional bioassay for arylsulfatase B using the natural substrates of the enzyme. | 2009 Dec 15 |
5 |
| 24 |
18285341 | Distinct effects of N-acetylgalactosamine-4-sulfatase and galactose-6-sulfatase expression on chondroitin sulfates. | 2008 Apr 11 |
7 |
| 25 |
17324393 | Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR. | 2007 May 1 |
2 |
| 26 |
17458871 | Mutational analysis of 105 mucopolysaccharidosis type VI patients. | 2007 Sep |
1 |
| 27 |
12796199 | Does deficiency of arylsulfatase B have a role in cystic fibrosis? | 2003 Jun |
2 |
| 28 |
15000815 | Identification of a novel mutation in the ARSB gene that is frequent among Brazilian MPSVI patients. | 2003 Winter |
2 |
| 29 |
11939792 | Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome): a Y210C mutation causes either altered protein handling or altered protein function of N-acetylgalactosamine 4-sulfatase at multiple points in the vacuolar network. | 2002 Apr 16 |
1 |
| 30 |
11668612 | Mucopolysaccharidosis type VI: Structural and clinical implications of mutations in N-acetylgalactosamine-4-sulfatase. | 2001 Oct |
2 |
| 31 |
1427856 | Feline arylsulfatase B (ARSB): isolation and expression of the cDNA, comparison with human ARSB, and gene localization to feline chromosome A1. | 1992 Oct |
2 |